Skip to main content
IKT
NASDAQ Life Sciences

Inhibikase Therapeutics Launches Pivotal Phase 3 Study, Reports Q1 Net Loss of $16.4M

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1.92
Mkt Cap
$253.503M
52W Low
$1.33
52W High
$2.27
52W Position info
44% above low
Off High info
15% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

IKT sits 44% above its 52-week low of $1.33 on light trading volume (0.3× avg).

Summary

Inhibikase Therapeutics reported Q1 2026 results, showing $0 revenue and a net loss of $(16.4) million, which widened from the prior year, though diluted EPS improved to $(0.10). Crucially, the company announced the initiation of its pivotal global Phase 3 IMPROVE-PAH study in April 2026, a significant operational milestone for the clinical-stage biotech. This increased spending on R&D and commercialization readiness explains the widened loss. The company also confirmed a cash runway of at least 12 months, supported by its ongoing ATM program, providing financial stability for the trial. Traders will closely monitor the progress of the Phase 3 study and future regulatory developments.

At the time of this announcement, IKT was trading at $1.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $253.5M. The 52-week trading range was $1.33 to $2.27. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

IKT - Latest Insights

IKT
Aug 26, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.57
Real-time Price: $1.39 info
Change: -$1.18 (-46%) info
Market Cap: $182.351M info
IKT
Aug 11, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.45
Real-time Price: $1.39 info
Change: -$1.06 (-43%) info
Market Cap: $182.351M info
IKT
Aug 11, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.45
Real-time Price: $1.39 info
Change: -$1.06 (-43%) info
Market Cap: $182.351M info
IKT
Jul 29, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.21
Real-time Price: $1.39 info
Change: -$0.820 (-37%) info
Market Cap: $182.351M info
IKT
Jul 23, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $1.39 info
Change: -$0.790 (-36%) info
Market Cap: $182.351M info